BAYN.DE BA

BAYN.DE Bayer AG N

Healthcare · Drug Manufacturers - General

1 · Weak Momentum 10.0 · Strong At risk

49.01

+0.55%

About the company

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a Strategic Alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

0.22%
0.11
48.1B
-1.76
40.39

52-week range

49.0
low 25.8 high 53.9
Yield Growth Momentum Safety Value Health

Dividend deep dive

Bayer AG N (BAYN.DE) is a German healthcare company operating in the Drug Manufacturers - General industry. Its current dividend yield of 0.23% is notably below its 5-year average of 2.71% and its 5-year high of 5.13%, indicating an overvalued status based on yield theory. The company's dividend safety is currently rated as at-risk, and it has a dividend streak of 0 years. The company's market capitalization is not available.

Dividend history

Bayer AG N has a dividend streak of 0 consecutive years of increases. Over the last three years, the dividend has decreased at a CAGR of -0.6197%, and over five years, it decreased at a CAGR of -0.4766%. Annual dividends per share have been: 2.0666 EUR (2014), 2.2142 EUR (2015), 2.4602 EUR (2016), 2.6571 EUR (2017), 2.7555 EUR (2018), 2.8 EUR (2019), 2.8 EUR (2020), 2.0 EUR (2021), 2.0 EUR (2022), 2.4 EUR (2023), and projected 0.11 EUR for both 2024 and 2025. Dividends are paid annually.

Dividend safety

The company's dividend safety is rated as at-risk. A current payout ratio is not available in the provided data, and FFO payout percentage is also not available as it is not a REIT.

Quantic · Free

Read the rest of the safety verdict

Plus the key risks and what to watch next — free, no card.

AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.

Price history

66.6 42.9 19.3 2021 2022 2023 2024 2025 2026 2020-07 · 55.5 2020-08 · 53.3 2020-09 · 40.4 2020-10 · 48.3 2020-11 · 48.2 2020-12 · 49.9 2021-01 · 50.1 2021-02 · 54.0 2021-03 · 53.8 2021-04 · 51.5 2021-05 · 51.2 2021-06 · 50.3 2021-07 · 47.1 2021-08 · 47.0 2021-09 · 48.7 2021-10 · 44.5 2021-11 · 47.0 2021-12 · 53.8 2022-01 · 51.5 2022-02 · 62.1 2022-03 · 62.9 2022-04 · 66.6 2022-05 · 56.7 2022-06 · 57.0 2022-07 · 52.6 2022-08 · 47.4 2022-09 · 53.2 2022-10 · 55.4 2022-11 · 48.3 2022-12 · 57.0 2023-01 · 56.3 2023-02 · 58.7 2023-03 · 59.8 2023-04 · 52.1 2023-05 · 50.7 2023-06 · 53.1 2023-07 · 50.5 2023-08 · 45.5 2023-09 · 40.7 2023-10 · 31.4 2023-11 · 33.6 2023-12 · 28.9 2024-01 · 28.1 2024-02 · 28.4 2024-03 · 27.4 2024-04 · 28.2 2024-05 · 26.4 2024-06 · 27.5 2024-07 · 27.9 2024-08 · 30.3 2024-09 · 24.8 2024-10 · 19.4 2024-11 · 19.3 2024-12 · 21.6 2025-01 · 22.7 2025-02 · 22.1 2025-03 · 23.0 2025-04 · 24.7 2025-05 · 25.5 2025-06 · 27.4 2025-07 · 28.1 2025-08 · 28.2 2025-09 · 26.9 2025-10 · 30.5 2025-11 · 37.0 2025-12 · 44.6 2026-01 · 42.0 2026-02 · 39.4 2026-03 · 38.0 2026-04 · 36.5 2026-05 · 48.4 2026-06 · 47.7 2026-07 · 47.7
Price

Dividend profile

Frequency
Annual
Growth (TTM)
+0.0%
CAGR 3y
-62.0%
-47.7%
0 years

(5-year)

Now 0.2%
0.4% avg 2.7% 5.1%

Payment calendar

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Dividend history

CAGR 3y -62.0% CAGR 5y -47.7%
14 15 16 17 18 19 20 21 22 23 24 25

Per-share dividend by year

Quantic · Free

Unlock valuation & strategy

Two DDM fair values, margin of safety, sector value rank, Dividend Yield Theory, doubling time and max drawdown.

Debt & leverage

134.3%
1.05
0.70
Debt vs cash
Debt Cash
Total debt
38.9B EUR
Total cash
6.7B EUR
10.2B EUR

Latest reported balance-sheet figures.

Held by 1 investor · watched by 1

Appears in these lists

BAYN.DE qualifies for these curated dividend rankings.

Information, not financial advice.

Quantic · Free

Track BAYN.DE and your whole portfolio

Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →